2 terminated, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow AT-752: new trials by email Literature Review of AT-752 trials Research Report on AT-752
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of AT-752 in Patients With Dengue Infection AT-752, Placebo - Dengue Fever | Phase 2 | Terminated | Atea Pharmaceuticals, Inc. | 21 | 2022-04-29 | 2024-03-05 |
| Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model AT-752, Placebo Comparator - Dengue | Phase 1 | Terminated | Atea Pharmaceuticals, Inc. | 5 | 2022-04-22 | 2023-04-21 |
| Study of AT-752 in Healthy Subjects AT-752, Placebo - Dengue | Phase 1 | Completed | Atea Pharmaceuticals, Inc. | 65 | 2021-03-09 | 2022-10-17 |
Dengue (3) · Hemorrhagic Fevers, Viral (1) · Infections (1) · Vector Borne Diseases (1) · Virus Diseases (1)
Atea Pharmaceuticals, Inc. (3)
Australia (1) · Brazil (1) · Colombia (1) · Ecuador (1) · India (1) · Malaysia (1) · Peru (1) · Philippines (1) · Taiwan (1) · Thailand (1) · United States (1) · Vietnam (1)